SEARCH

SEARCH BY CITATION

References

  • 1
    Sibai BM. Medical disorders in pregnancy, including hypertensive diseases. Curr Opin Obstet Gynecol 1990; 2: 1322.
  • 2
    Van Beek E, Peelers LLH. Pathogenesis of preeclampsia: a comprehensive model. Obstet Gynecol Survey 1998; 53: 233239.
  • 3
    Meekins JW, Pijnenborg R, Hanssens M, McFayden IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies. Br J Obstet Gynaecol 1994; 101: 669674.
  • 4
    Starzyk KA, Salafia CM, Pezzullo JC et al. Quantitative difference in arterial morphometry define placental bed in preeclampsia. Human Pathol 1997; 28: 353358.
  • 5
    Pijnenborg R, Anthony J, Davey DA et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648655.
  • 6
    Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 1991; 18: 661682.
  • 7
    Sen C, Madazli R, Kavuzlu C, Ocak V, Tolun N. The value of antithrombin-III and fibronectin in hypertensive disorders of pregnancy. J Perinat Med 1994; 22: 2938.
  • 8
    Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia. Br J Obstet Gynaecol 1994; 101: 488492.
  • 9
    Friedman SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 1995; 172: 202203.
  • 10
    Pearlberg KM, De Jong CL, van Geijn HP, van Kamp GJ, Heinen AG, Dekker GA. Total plasma fibronectin as a marker of pregnancy induced hypertensive disorders: a longitudinal study. Obstet Gynecol 1988; 91: 383388.
  • 11
    Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neu-trophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989; 96: 978982.
  • 12
    Prieto JA, Panyutich AV, Heine RP. Neutrophil activation in preeclampsia. Are defensins and lactoferrin elevated in preeclamptic patients J Reprod Med 1997; 42: 2932.
  • 13
    Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation Br J Obstet Gynaecol 1994; 101: 485487.
  • 14
    Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71: 5358.
  • 15
    Budak E, Madazli R, Aksu MF et al. Vascular cell adhesion molecule (VCAM-1) and leukocyte activation in preeclampsia and eclampsia. Int J Obstet Gynaecol 1998; 63: 115121.
  • 16
    Robertson WB, Khong TY, Brosens I, De Wolf F, Sheppard BL, Bonnar J. The placental bed biopsy: Review from three European centers. Am J Obstet Gynecol 1986; 155: 401412.
  • 17
    Wallenburg HCS, Visser W. Pregnancy-induced hypertensive disorders. Curr Opin Obstet Gynecol 1994; 6: 1929.
  • 18
    Pijnenborg R, Luyten C, Vercruysse L, van Assche A. Attachment and differentiation of trophoblast from normal and preeclamptic human placentas. Am J Obstet Gynecol 1996; 175: 3036.
  • 19
    Pijnenborg R, Anthony J, Davey DA et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648655.